๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market โ€” 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
491 results for โ€œNovoโ€
MedicineActive substanceLicence holderStatus
Paglitaz
EU/1/11/721/015-021
Pioglitazone hydrochloride KRKA, d.d., Novo mesto โ€”
Paliperidone Krka 3 mg prolonged-release tablets
PA1347/092/001
Paliperidone KRKA, d.d., Novo mesto Marketed
Paliperidone Krka 6 mg prolonged-release tablets
PA1347/092/002
Paliperidone KRKA, d.d., Novo mesto Marketed
Paliperidone Krka 9 mg prolonged-release tablets
PA1347/092/003
Paliperidone KRKA, d.d., Novo mesto Marketed
Paracetamol Krka 500 mg tablets
PA1347/095/001
Paracetamol KRKA, d.d., Novo mesto Not marketed
Perindopril arginine/Indapamide/Amlodipine Krka 10 mg/2.5 mg/10 mg tablets
PA1347/112/003
Perindopril arginine, Indapamide, Amlodipine besilate KRKA, d.d., Novo mesto Not marketed
Perindopril arginine/Indapamide/Amlodipine Krka 10 mg/2.5 mg/5 mg tablets
PA1347/112/002
Perindopril arginine, Indapamide, Amlodipine besilate KRKA, d.d., Novo mesto Not marketed
Perindopril arginine/Indapamide/Amlodipine Krka 5 mg/1.25 mg/5 mg tablets
PA1347/112/001
Perindopril arginine, Indapamide, Amlodipine besilate KRKA, d.d., Novo mesto Not marketed
Perindopril Krka 2 mg tablets
PA1347/041/001
Perindopril tert-butylamine KRKA, d.d., Novo mesto Marketed
Perindopril Krka 4 mg tablets
PA1347/041/002
Perindopril tert-butylamine KRKA, d.d., Novo mesto Marketed
Perindopril Krka 8 mg tablets
PA1347/041/003
Perindopril tert-butylamine KRKA, d.d., Novo mesto Marketed
Perindopril/amlodipine Krka 4 mg/10 mg tablets
PA1347/084/002
Perindopril tert-butylamine, Amlodipine besilate KRKA, d.d., Novo mesto Not marketed
Perindopril/amlodipine Krka 4 mg/5 mg tablets
PA1347/084/001
Perindopril tert-butylamine, Amlodipine besilate KRKA, d.d., Novo mesto Not marketed
Perindopril/amlodipine Krka 8 mg/10 mg tablets
PA1347/084/004
Perindopril tert-butylamine, Amlodipine besilate KRKA, d.d., Novo mesto Not marketed
Perindopril/amlodipine Krka 8 mg/5 mg tablets
PA1347/084/003
Perindopril tert-butylamine, Amlodipine besilate KRKA, d.d., Novo mesto Not marketed
Pomalidomide Krka 1 mg hard capsules
EU/1/24/1832/001-002
Pomalidomide Krka, d.d., Novo mesto โ€”
Pomalidomide Krka 2 mg hard capsules
EU/1/24/1832/003-004
Pomalidomide Krka, d.d., Novo mesto โ€”
Pomalidomide Krka 3 mg hard capsules
EU/1/24/1832/005-006
Pomalidomide Krka, d.d., Novo mesto โ€”
Pomalidomide Krka 4 mg hard capsules
EU/1/24/1832/007-008
Pomalidomide Krka, d.d., Novo mesto โ€”
Prandin
EU/1/00/162/002
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/003
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/004
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/005
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/006
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/007
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/008
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/009
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/010
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/011
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/012
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/013
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/014
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/015
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/016
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/017
Repaglinide Novo Nordisk A/S โ€”
Prandin
EU/1/00/162/018
Repaglinide Novo Nordisk A/S โ€”
PRANDIN
EU/1/00/162/001
Repaglinide Novo Nordisk A/S โ€”
Prasugrel Krka 10 mg Film-coated tablets
PA1347/080/002
Prasugrel KRKA, d.d., Novo mesto Not marketed
Prasugrel Krka 5 mg Film-coated tablets
PA1347/080/001
Prasugrel KRKA, d.d., Novo mesto Not marketed
Pregabalin Krka 100 mg hard capsules
PA1347/050/004
Pregabalin KRKA, d.d., Novo mesto Marketed
Pregabalin Krka 150 mg hard capsules
PA1347/050/005
Pregabalin KRKA, d.d., Novo mesto Marketed
Pregabalin Krka 200 mg hard capsules
PA1347/050/006
Pregabalin KRKA, d.d., Novo mesto Marketed
Pregabalin Krka 225 mg hard capsules
PA1347/050/007
Pregabalin KRKA, d.d., Novo mesto Not marketed
Pregabalin Krka 25mg hard capsules
PA1347/050/001
Pregabalin KRKA, d.d., Novo mesto Marketed
Pregabalin Krka 300 mg hard capsules
PA1347/050/008
Pregabalin KRKA, d.d., Novo mesto Marketed
Pregabalin Krka 50 mg hard capsules
PA1347/050/002
Pregabalin KRKA, d.d., Novo mesto Marketed
Pregabalin Krka 75 mg hard capsules
PA1347/050/003
Pregabalin KRKA, d.d., Novo mesto Marketed
Protaphane
EU/1/02/234/016-017
Insulin human Novo Nordisk A/S โ€”
Protaphane
EU/1/02/234/1-15
Insulin human Novo Nordisk A/S โ€”
Quentiax SR 150mg prolonged-release tablets
PA1347/045/001
Quetiapine hemifumarate KRKA, d.d., Novo mesto Marketed
โ† 4 5 6 7 8 9 10 โ†’

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.